课题基金 / 基金详情

The Impact of Obesity, Cardiovascular Diseases and Diabetes on Labor Market Participation and Productivity

The Impact of Obesity, Cardiovascular Diseases and Diabetes on Labor Market Participation and Productivity
肥胖、心血管疾病和糖尿病对劳动力市场参与度和生产力的影响
批准号:
508083523
负责人:
Professor Dr. Holger Strulik
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
--
资助国家:
德国
项目状态:
未结题
起止时间:

项目摘要

项目成果

Professor Dr. Holger Strulik的其他基金

相似基金

相关文献

中文摘要
翻译
自1975年以来,全球范围内的肥胖症几乎增加了两倍。尽管估计表明肥胖的遗传率超过60%,但人类表型的演变不能用基因的变化来解释,因为它发生得太快了。因此,对肥胖症流行的普遍解释是基因与环境的相互作用。虽然从中期来看,基因类型是外源决定和固定的,但个体对不断变化的肥胖环境(节省劳动力的技术、价格、可获得性和食物的能量含量)的反应在很大程度上是遗传的。这些观察结果是对我们研究的启发。本研究计划包括三个工作包。第一个工作包侧重于经验性地估计肥胖、糖尿病、心血管疾病和高血压对就业、工资和其他劳动力市场结果的因果影响。我们使用遗传标记作为疾病的工具,并通过控制暴露在日益肥胖的环境中的持续时间来考虑基因与环境的相互作用。我们使用从健康和退休研究(HRS)获得的一大批出生于1900至1958年间的美国成年人的基因数据和劳动力市场结果,并将其与从全基因组关联研究获得的遗传信息相结合。在工作包2中,我们调查了肥胖与人类老龄化过程中其他健康缺陷的发展之间的关系。我们通过构建脆弱指数来衡量个体健康,该指数将生物衰老过程定义为内在的、累积的、渐进性的和有害的功能丧失。我们使用与WP 1相同的数据来源和工具变量策略来确定肥胖对生理衰老的影响。然后,我们测试肥胖对劳动力市场结果的影响是否以及在多大程度上是通过增加脆弱性来调节的。在工作包3中,我们使用经验发现来开发肥胖的新经济理论,该理论解释了体重的演变及其对健康、老龄化、生产力和劳动力供应的影响。具体地说,我们进一步发展了健康赤字模型,该模型使用脆弱指数作为衡量人类健康和老龄化的指标。我们还考察了有限理性行为在不完全自我控制和时间不一致决策中的作用。我们用HRS数据和WP 1和WP 2的结果校准了模型的数字版本,并使用这些模型来推断食品价格变化、医疗进步和遏制肥胖症流行的政策干预所引发的行为变化。
英文摘要
Worldwide obesity has nearly tripled since 1975. Although estimates suggest heritability of obesity of more than 60 percent, the evolving human phenotype cannot be explained by a changing genotype because it occurred too rapidly. The prevailing explanation for the obesity epidemic is thus gene-environment interaction. While genotypes are exogenously determined and fixed in the medium run, the individual response to a changing obesogenic environment (labor saving technology, price, availability, and energy content of food) is largely genetic. These observations are the inspiration for our study.The proposed research project consists of three work packages. The first work package focuses on empirically estimating the causal effect of obesity, diabetes, CVDs, and hypertension on employment, wages, and other labor market outcomes. We use genetic markers as instruments for the diseases and take gene-environment interaction into account by controlling for the duration of exposure to an increasingly obesogenic environment. We use genotyped data and labor market outcomes from a large panel of US American adults born between 1900 and 1958 obtained from the Health and Retirement Study (HRS) and combine it with genetic information obtained from genome-wide association studies.In work package 2, we investigate the association between obesity and the development of other health deficits in the course of human aging. We measure individual health by constructing a frailty index, which captures in one number the biological aging process defined as the intrinsic, cumulative, progressive, and deleterious loss of function. We use the same data sources and instrumental variable strategy as WP 1 to determine the impact of obesity on physiological aging. We then test whether and to which extent the impact of obesity on labor market outcomes is mediated through increasing frailty. In work package 3 we use the empirical findings to develop a new economic theory of obesity, which explains the evolution of body weight and its impact on health, aging, productivity, and labor supply. Specifically, we further develop the health deficit model, which uses the frailty index as measure of human health and aging. We also investigate the role of bounded rational behavior in form of imperfect self-control and time inconsistent decision making. We calibrate numerical versions of the model with the HRS data and the results from WP 1 and 2 and use these models for inferences on the behavioral changes that are elicited by changing food prices, medical progress, and policy interventions to curb the obesity epidemic.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Socioeconomic Health Gradient and Rising Old-Age Inequality
Optimal Health and Retirement Policy Under Biologically Founded Human Ageing
Je ne regrette rien? Present-Bias and Time-Inconsistent Health and Retirement Decisions
海外基金